Related Experiment Video
Updated: Jun 3, 2026
08:27
Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat
Published on: October 29, 2014
Systematic review: neonatal meningitis in the developing world.
J S Furyk1, O Swann, E Molyneux
1James Cook University, School of Public Health, Tropical Medicine and rehabilitation sciences, Townsville, Australia. Jeremy_Furyk@health.qld.gov.au
Tropical Medicine & International Health : TM & IH
|March 15, 2011
Summary
Neonatal meningitis is a major global health issue, particularly in developing nations where mortality rates are significantly higher. Understanding regional pathogen differences is crucial for effective treatment strategies.
Area of Science:
- Neonatal infectious diseases
- Global public health
- Microbiology
Background:
- Neonatal meningitis poses a significant global health burden, with higher mortality in developing countries (40-58%) compared to developed nations (10%).
- Existing research predominantly originates from high-income countries, potentially overlooking critical differences in disease epidemiology and causative agents in resource-limited settings.
Purpose of the Study:
- To highlight the disparities in neonatal meningitis epidemiology and causative pathogens between developed and developing countries.
- To inform the selection of appropriate empiric antibiotic therapy based on local data and resource availability.
Main Methods:
- Comparative analysis of existing literature focusing on neonatal meningitis prevalence and etiology.
- Review of pathogen profiles from cerebrospinal fluid cultures in diverse geographical settings.
Main Results:
- Significant differences in the spectrum of pathogens causing neonatal meningitis are observed between developed and developing countries.
- While Group B Streptococcus (GBS) and Escherichia coli are common in developed nations, developing countries show varied results, including other Gram-negative bacteria, Listeria, and Gram-positive organisms.
Conclusions:
- Empiric antibiotic choices for neonatal meningitis must consider local epidemiological data, resistance patterns, and drug availability.
- Further research is needed to address knowledge gaps, explore adjuvant therapies, and improve outcomes in resource-limited settings.
Related Concept Videos
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
01:18Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
01:24Bacterial Meningitis
Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...